Wargo, French & Singer LLP partner Alina Singer and associate Aaron Bibbee represented a multinational Fortune 100 pharmaceutical company in connection with the renewal and consolidation of a large‑scale, cross‑supply arrangement with another multinational Fortune 500 pharmaceutical company governing the manufacture, purchase, and supply of finished pharmaceutical products and related active pharmaceutical ingredients. The transaction, valued at $200M, refreshed and streamlined legacy manufacturing and supply frameworks into harmonized, forward‑looking agreements designed to support long‑term commercial stability while preserving flexibility in a volatile regulatory and market environment.The matter highlights the firm’s ability to navigate complex pharmaceutical supply relationships and to craft commercially precise contract architecture tailored to high‑value, long‑duration arrangements.
In Q1 of 2026, Wargo, French & Singer LLP partner Alina Singer and associate MaKayla Owens closed a series of complex, multi‑step corporate transactions with a cumulative value of more than $125 million. The transactions involved a spin-off of a media company from a larger multinational Fortune 50 telecommunications company, a reverse triangular merger on behalf of the media company client for the acquisition of another media company, and a series of related contributions and exchanges to implement the agreed earn-out mechanics. The engagement exemplifies the firm’s ability to deliver strategic legal guidance across highly sophisticated M&A transactions characterized by complex structural, legal, and operational dynamics.
Learn more about member firm from Atlanta, Georgia, USA, Wargo, French & Singer LLP, here.